EFPIA - NEWSLETTER

EFPIA Newsletter 24 March 2022

News

23 March 2022 Joint Industry Statement on the War in Ukraine

We are united in our mission of providing treatments and vaccines to all those affected by the war, wherever they are....

05 October 2022 Pharmaceutical industry response to the war in Ukraine

Supporting people affected by the war

Blogs

24 March 2022 Multiple Myeloma Awareness Month: A Commitment to Being Ambitious for Patients

I’m optimistic we can change the trajectory of multiple myeloma. We won't settle for anything less.

23 March 2022 AI and competitiveness angle from a patient view point

People must be at the heart of everything that is done and it is through appropriate investments in education, training...

Events

29 MAR 2022

DIA Europe 2022 Hybrid conference (virtual - Brussels)

Advancing Health Priorities

Learn more →

25 APR 2022

Sustainable Continence Care Symposium 2022 Tampere, Finland

Technologies and Infrastructures of Sustainable Continence Care

Learn more →

27 JUN 2022

11th European Conference on Rare Diseases & Orphan Products Virtual event

Putting rare diseases policy into action.

Learn more →

15 OCT 2022

35th Annual Congress of the European Association of Nuclear Medicine CCIB, Barcelona International Convention Centre

The EANM Annual Congress is the most valuable Nuclear Medicine Meeting worldwide.

Learn more →

What we are reading

Western drugmakers walk ethical tightrope over Russian ties 18 March 2022 (Financial Times)

Fake it till you make drugs 23 March 2022 (Euractiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶